EP3169362

METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    16.7.2015
  • EP published:
    10.6.2020
  • EP application number:
    15760317.6
  • Max expiry date:
    15.7.2035
  • Title:
    METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA

Timeline

Today
16.7.2015EP application
10.6.2020EP Publication

Owner

  • Name:
    Sanofi Biotechnology
  • Address:
    54 rue La Boétie, 75008 Paris, FR
  • Name:
    Regeneron Pharmaceuticals, Inc.
  • Address:
    777 Old Saw Mill River Road, Tarrytown, NY 10591, US

Inventor

  • Name:
    HANOTIN, Corinne
  • Address:
    F-75008 Paris, FR
  • Name:
    BESSAC, Laurence
  • Address:
    F-75008 Paris, FR
  • Name:
    CHAUDHARI, Umesh
  • Address:
    Bridgewater, NJ 08807, US
  • Name:
    PORDY, Robert
  • Address:
    Tarrytown, NY 10591, US
  • Name:
    SCHWEMMER GIPE, Daniel A.
  • Address:
    Tarrytown, NY 10591, US

Priority

  • Number:
    201462025371 P
  • Date:
    16.7.2014
  • Country:
    US
  • Number:
    201462043167 P
  • Date:
    28.8.2014
  • Country:
    US
  • Number:
    201462080725 P
  • Date:
    17.11.2014
  • Country:
    US
  • Number:
    201562132709 P
  • Date:
    13.3.2015
  • Country:
    US
  • Number:
    15305830
  • Date:
    29.5.2015
  • Country:
    EP

Classification

  • Categories:
    C07K 16/40, A61K 39/00, A61K 39/395

Upload documents